Find News

Filter articles

Applied Filters

Showing 1 to 10 of 266 results

Roche urges SCOTUS to cancel Illumina patent win

US08-01-2021Rory O'Neill

Roche has asked the US Supreme Court to declare that methods of separating DNA are not patent-eligible.

Ravgen and Myriad in patent dispute over DNA testing tech


Biotechnology company Ravgen has accused Myriad Genetics and Myriad Women’s Health of infringing two patents covering non-invasive DNA testing technology.

Eli Lilly seals $1bn genetics deal

17-12-2020Rory O'Neill

Eli Lilly is expanding its genetics business with the $880 million purchase of Prevail Therapeutics, in a deal that could rise to more than $1 billion.

Illumina, Roche accused of infringing genetic testing patents

US07-12-2020Muireann Bolger

Pharmaceutical companies Illumina and Roche have been sued for allegedly infringing two patents covering the technology for non-invasive DNA testing by Maryland genetic testing company Ravgen.

Abbott must face HIV testing patent suit, rules judge

US04-12-2020Sarah Morgan

Abbott Laboratories must face allegations brought by Grifols Diagnostic and a Novartis subsidiary that its HIV testing products infringe a patent covering a method to create HIV proteins using recombinant DNA. 

EPO reveals decision behind Broad patent revocation

EU, US09-11-2020Sarah Morgan

The European Patent Office has released the long-awaited reasoning for its decision to uphold the revocation of a Broad Institute CRISPR/Cas9 patent. In January this year, the EPO’s Board of Appeal concluded that the Broad’s patent, EP2,771,468, lacked novelty due to an invalid claim to priority. The EPO dealt with three questions in its reasoning.

Bayer to spend up to $4bn on Asklepios BioPharmaceutical

Germany, US27-10-2020Sarah Morgan

Germany-based Bayer will pay up to $4 billion to acquire gene therapy company Asklepios BioPharmaceutical.

DNA start-up refused UK trademark

UK15-10-2020Rory O'Neill

An Australian personalised genomics company has failed in its effort to obtain protection for its ‘’ trademark in the UK.

Australian court rejects cattle genome patent appeal

Australia12-10-2020Sarah Morgan

The Federal Court of Australia has refused to block a cattle genome patent from the US, dismissing an appeal from Meat and Livestock Australia.

ERS Genomics appoints vice-president of IP

Ireland, US23-09-2020Sarah Morgan

ERS Genomics, the company that provides access to CRISPR/Cas9 IP owned by researcher Emmanuelle Charpentier, has appointed Michael Arciero as vice-president of IP and commercial development.

Showing 1 to 10 of 266 results